Phase II Study of Sequential Methotrexate and 5-Fluorouracil Chemotherapy Against Peritoneally Disseminated Gastric Cancer with Malignant Ascites: a Report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial

T. Yamao; Y. Shimada; K. Shirao; A. Ohtsu; N. Ikeda; I. Hyodo; H. Saito; H. Iwase; Y. Tsuji; T. Tamura; S. Yamamoto; S. Yoshida

doi:10.1093/jjco/hyh063

Phase II Study of Sequential Methotrexate and 5-Fluorouracil Chemotherapy Against Peritoneally Disseminated Gastric Cancer with Malignant Ascites: a Report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyh063 ◽

2004 ◽

Vol 34 (6) ◽

pp. 316-322 ◽

Cited By ~ 36

Author(s):

T. Yamao ◽

Y. Shimada ◽

K. Shirao ◽

A. Ohtsu ◽

N. Ikeda ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Malignant Ascites ◽

Study Group ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Sequential Methotrexate

Download Full-text

A Phase II Study of Sequential Methotrexate and 5-fluorouracil Chemotherapy in Previously Treated Gastric Cancer: A Report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 Trial

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyn043 ◽

2008 ◽

Vol 38 (6) ◽

pp. 432-437 ◽

Cited By ~ 13

Author(s):

T. Hamaguchi ◽

K. Shirao ◽

N. Yamamichi ◽

I. Hyodo ◽

W. Koizumi ◽

...

Keyword(s):

Gastric Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Previously Treated ◽

Sequential Methotrexate

Download Full-text

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)

Gastric Cancer ◽

10.1007/s10120-011-0030-8 ◽

2011 ◽

Vol 14 (3) ◽

pp. 226-233 ◽

Cited By ~ 12

Author(s):

Tetsuya Hamaguchi ◽

◽

Kuniaki Shirao ◽

Atsushi Ohtsu ◽

Ichinosuke Hyodo ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group

Download Full-text

Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: Report from the Japan Clinical Oncology Group (JCOG)

European Journal of Cancer ◽

10.1016/0959-8049(94)00350-e ◽

1994 ◽

Vol 30 (14) ◽

pp. 2091-2093 ◽

Cited By ~ 39

Author(s):

A. Ohtsu ◽

Y. Shimada ◽

S. Yoshida ◽

H. Saito ◽

S. Seki ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group

Download Full-text

A phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: the Japan Clinical Oncology Group trial (JCOG0109)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4071 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4071-4071 ◽

Cited By ~ 1

Author(s):

T. Hamaguchi ◽

A. Ohtsu ◽

I. Hyodo ◽

Y. Arai ◽

H. Takiuchi ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Group Trial

Download Full-text

A phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: the Japan Clinical Oncology Group trial (JCOG0109)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4071 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4071-4071

Author(s):

T. Hamaguchi ◽

A. Ohtsu ◽

I. Hyodo ◽

Y. Arai ◽

H. Takiuchi ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Advanced Gastric Cancer ◽

Mitomycin C ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Group Trial

Download Full-text

A Phase II Study of Doxifluridine in Elderly Patients with Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG 9410)

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyf022 ◽

2002 ◽

Vol 32 (3) ◽

pp. 90-94 ◽

Cited By ~ 8

Author(s):

N. Ikeda

Keyword(s):

Gastric Cancer ◽

Elderly Patients ◽

Advanced Gastric Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study

Download Full-text

Phase II Study of Laparoscopy-assisted Distal Gastrectomy with Nodal Dissection for Clinical Stage I Gastric Cancer: Japan Clinical Oncology Group Study JCOG0703

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyn055 ◽

2008 ◽

Vol 38 (7) ◽

pp. 501-503 ◽

Cited By ~ 21

Author(s):

Y. Kurokawa ◽

H. Katai ◽

H. Fukuda ◽

M. Sasako ◽

Keyword(s):

Gastric Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Distal Gastrectomy ◽

Phase Ii Study ◽

Clinical Stage ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Nodal Dissection

Download Full-text

Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508

International Journal of Hematology ◽

10.1007/s12185-012-1101-2 ◽

2012 ◽

Vol 96 (1) ◽

pp. 74-83 ◽

Cited By ~ 3

Author(s):

Yoshitoyo Kagami ◽

◽

Kuniaki Itoh ◽

Kensei Tobinai ◽

Haruhiko Fukuda ◽

...

Keyword(s):

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Hodgkin's Lymphoma ◽

Intermediate Risk ◽

Newly Diagnosed ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study ◽

Chop Therapy

Download Full-text

A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients: Japan Clinical Oncology Group Study JCOG9203

International Journal of Hematology ◽

10.1532/ijh97.05084 ◽

2006 ◽

Vol 83 (1) ◽

pp. 55-62 ◽

Cited By ~ 5

Author(s):

Fumi Mizoroki ◽

Yuko Hirose ◽

Masayuki Sano ◽

Haruhiko Fukuda ◽

Kensei Tobinai ◽

...

Keyword(s):

Elderly Patients ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Aggressive Lymphoma ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Oncology Group Study

Download Full-text

Standard CHOP therapy for low (L) or low-intermediate (L-I) risk patients (pts) with aggressive non-Hodgkin's lymphoma (NHL): A multicenter phase II study by Japan Clinical Oncology Group (JCOG 9508)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.6703 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6703-6703

Author(s):

M. Ogura ◽

Y. Kagami ◽

K. Itoh ◽

K. Tobinai ◽

T. Chou ◽

...

Keyword(s):

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Study ◽

Hodgkin's Lymphoma ◽

Oncology Group ◽

Japan Clinical Oncology Group ◽

Multicenter Phase ◽

Non Hodgkin's Lymphoma ◽

Risk Patients ◽

Chop Therapy

Download Full-text